Fibrosing colonopathy is a complication recently detected in children with
cystic fibrosis (CF), and is thought to be associated with the use of high-
strength pancreatic enzymes. The goal of this study was to evaluate the eff
ectiveness of magnetic resonance (MR) in detecting possible pathologic gat
findings in patients with CF under pancreatic enzyme treatment. Twenty-five
patients with CF and pancreatic insufficiency, all under treatment with hi
gh-dose pancreatic enzymes, were studied by MR. MR was performed on a 1.5-T
magnet by T1-weighted, 2D-FLASH fat-suppression, breath-hold sequences bef
ore and after intravenous administration of gadolinium, and by T2-weighted
Turbo Spin-Echo (TSE) and Half-Fourier Acquisition Single-Shot Turbo, Spin
Echo (HASTE) fat-suppression, breath-hold sequences. A superparamagnetic ne
gative oral contrast agent was given 1.5 h before the examination. MR showe
d a wall thickening of the terminal ileum and the ascending colon (>4-12 mm
) in 22 patients; nine of them (wall thickness > 4-6 min) showed both a mod
erate hyperintensity of the bowel wall on T2-weighted sequences and an enha
ncement after intravenous gadolinium. on T1-weighted sequences; 13 patients
(wall thickness > 6-12 mm) showed both a great wall enhancement after intr
avenous gadolinium and an increased signal intensity of the bowel wall on T
2-weighted sequences. Fecal impaction without bowel wall involvement was de
tected in three patients. MR proved to be a useful, noninvasive, diagnostic
tool for the evaluation of patients with CF and fibrosing colonopathy. The
signal hyperintensity on T2-weighted sequences and the great wall enhancem
ent after intravenous gadolinium administration indicating an acute edemato
us condition, provide the clinicians useful information for the therapeutic
adjustment. (C) 2001 Elsevier Science Inc. All rights reserved.